Third Party Funds Group - Overall project
Acronym: moveIT
Start date : 01.01.2018
End date : 31.12.2018
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder (10 mio. patients worldwide) with increasing prevalence in western societies. Gait impairment and falls strongly reduce quality of life for PD patients, lead to severe comorbidities, and cause substantial healthcare costs. Scientific evidence shows that adequate treatment may increase mobility, reduce risk-of-falling, prevent falls, and reduce cost. However, technologies to comprehensively monitor gait&falls are not available or fail to qualify as a medical service or product, and can therefore not be applied clinically in multidisciplinary healthcare concepts to improve PD patient mobility.
This project will generate the first comprehensive gait&fall assessment battery integrated into a multidisciplinary healthcare concept by establishing an innovative digital health pathway for gait&falls in PD. Existing well-characterised patient cohorts and state-of-the-art healthcare concepts will be used in a Living Lab to develop, test, and validate sensor-based movement assessments for application in clinical studies and patient care, ultimately preventing falls by moving PD healthcare into digital health.
Parkinson’s disease (PD) is a chronic movement disorder characterized by progressive gait impairment, leading to reduced mobility, poor quality of life and frequent falls. moveIT improves healthcare for patients via wearable gait&fall sensors enabled as healthcare products by an innovative digital health pathway (DHP). The DHP defines the clinical application of these new technologies for multidisciplinary healthcare using stratified patient cohorts and care networks targeting gait&falls in PD.